Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. Isracann has secured 3 farms in Israel with cultivation licenses totalling 580,000 sq. ft.
Located in the cannabis research capital of the world, Isracann has relationships with the research, scientific and medical community to identify opportunities and develop pipeline of drugs and devices.
The company is targeting an undersupplied domestic market and anticipates
near-term expansion to major European marketplaces.